Skip to main content
Medical information Clinical review pending

Cytogenetics

Immunohistochemistry Chromogranina CGA Test

The Immunohistochemistry Chromogranina CGA Test helps identify neuroendocrine tumors by measuring chromogranin A levels in tissue samples. This test aids oncologists and pathologists in diagnosing and managing certain cancers.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Submit tumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, site of biopsy, and clinical history.
Results
Sample daily by 6 pm; Report Block: 5 days; Tissue Biopsy: 5 days; Tissue large complex: 7 days.
Preparation
Provide a copy of the Histopathology report, site of biopsy, and clinical history.
Test priceKSh 6,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunohistochemistry Chromogranina CGA Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspicion of neuroendocrine tumor
  • ✓Diagnosis of unknown primary tumor
  • ✓Characterization of certain cancers
  • ✓Monitoring treatment response in neuroendocrine tumors
  • ✓Evaluation of patients with relevant symptoms (e.g., flushing, diarrhea, abdominal pain)
02

In plain language

What this test helps you understand

Aids in the diagnosis and characterization of neuroendocrine tumors. Helps guide treatment decisions and monitor disease progression.
The Immunohistochemistry Chromogranina CGA Test is a specialized diagnostic tool used primarily in oncology. It detects chromogranin A (CGA) levels in tumor tissues, playing a crucial role in identifying neuroendocrine tumors. This information significantly impacts treatment decisions and patient outcomes. By utilizing advanced immunohistochemistry techniques, this test provides oncologists and pathologists with essential insights into tumor biology. This test measures the presence of chromogranin A, a protein often elevated in patients with neuroendocrine tumors. Elevated levels can indicate the presence of certain types of cancer, aiding in both diagnosis and monitoring treatment effectiveness. Individuals experiencing symptoms like unexplained weight loss, persistent abdominal pain, or hormonal imbalances may benefit from this test. Patients with risk factors for neuroendocrine tumors, such as a family history, should also discuss this test with their healthcare provider. Results indicate the levels of chromogranin A in the tumor tissue. Elevated levels may suggest neuroendocrine tumors, while normal levels can provide reassurance. Discuss your results with your oncologist for a full understanding.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationProvide a copy of the Histopathology report, site of biopsy, and clinical history.
SampleSubmit tumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, site of biopsy, and clinical history.
MethodologyImmunohistochemistry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test is specific for chromogranin A and may not detect all types of neuroendocrine tumors. Results must be interpreted in the context of clinical findings and other diagnostic tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Chromogranin A is a protein found in neuroendocrine cells. Elevated levels in tumor tissue can indicate the presence of a neuroendocrine tumor.
This test helps doctors diagnose neuroendocrine tumors, which are a specific type of cancer. Early diagnosis is crucial for effective treatment.
A tissue sample from a biopsy or surgery is required. This sample should be preserved in formalin or formalin-saline.
Turnaround time varies depending on the sample type, typically ranging from 5 to 7 days. Confirm with the laboratory before booking.
A pathologist will analyze the test results, and your oncologist will discuss the findings and their implications with you.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp